For Vulcan Materials Co (NYSE:VMC), Vertical Research upgraded the previous rating of Hold to Buy. For the second quarter, Vulcan Materials had an EPS of $1.53, compared to year-ago quarter EPS of $1.57. The current stock performance of Vulcan Materials shows a 52-week-high of $213.65 and a 52-week-low of $137.54. Moreover, at the end of the last trading period, the closing price was at $166.49.

For Okta Inc (NASDAQ:OKTA), Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. In the second quarter, Okta showed an EPS of $0.10, compared to $0.11 from the year-ago quarter. The current stock performance of Okta shows a 52-week-high of $226.49 and a 52-week-low of $77.01. Moreover, at the end of the last trading period, the closing price was at $91.40.

Raymond James downgraded the previous rating for Bed Bath & Beyond Inc (NASDAQ:BBBY) from Market Perform to Underperform. In the first quarter, Bed Bath & Beyond showed an EPS of $2.83, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $30.06 and a 52-week-low of $4.38. At the end of the last trading period, Bed Bath & Beyond closed at $9.53.

Goldman Sachs downgraded the previous rating for Codiak BioSciences Inc (NASDAQ:CDAK) from Buy to Neutral. In the second quarter, Codiak BioSciences showed an EPS of $0.30, compared to $0.99 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.48 and a 52-week-low of $2.10. Codiak BioSciences closed at $2.15 at the end of the last trading period.

With a Neutral rating, Citigroup initiated coverage on Open Text Corp (NASDAQ:OTEX). The price target seems to have been set at $34.00 for Open Text. In the fourth quarter, Open Text showed an EPS of $0.80, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $48.46 and a 52-week-low of $30.83. At the end of the last trading period, Open Text closed at $31.48.

With a Buy rating, Citigroup initiated coverage on Ceridian HCM Holding Inc (NYSE:CDAY). The price target seems to have been set at $73.00 for Ceridian HCM Holding. For the second quarter, Ceridian HCM Holding had an EPS of $0.21, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $105.50 and a 52-week-low of $43.23. At the end of the last trading period, Ceridian HCM Holding closed at $59.64.

Citigroup initiated coverage on Instructure Holdings Inc (NYSE:INST) with a Buy rating. The price target for Instructure Holdings is set to $30.00. In the second quarter, Instructure Holdings showed an EPS of $0.25, compared to $0.16 from the year-ago quarter. The current stock performance of Instructure Holdings shows a 52-week-high of $25.84 and a 52-week-low of $15.68. Moreover, at the end of the last trading period, the closing price was at $22.73.

Citigroup initiated coverage on Paycom Software Inc (NYSE:PAYC) with a Buy rating. The price target for Paycom Software is set to $457.00. In the second quarter, Paycom Software showed an EPS of $1.26, compared to $0.97 from the year-ago quarter. The stock has a 52-week-high of $416.08 and a 52-week-low of $255.82. At the end of the last trading period, Paycom Software closed at $351.20.

With a Neutral rating, Citigroup initiated coverage on Paycor HCM Inc (NASDAQ:PYCR). The price target seems to have been set at $30.00 for Paycor HCM. Paycor HCM earned $0.04 in the fourth quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Paycor HCM shows a 52-week-high of $34.95 and a 52-week-low of $20.14. Moreover, at the end of the last trading period, the closing price was at $29.63.

Citigroup initiated coverage on Paylocity Holding Corp (NASDAQ:PCTY) with a Neutral rating. The price target for Paylocity Holding is set to $294.00. For the fourth quarter, Paylocity Holding had an EPS of $0.80, compared to year-ago quarter EPS of $0.46. At the moment, the stock has a 52-week-high of $276.88 and a 52-week-low of $152.01. Paylocity Holding closed at $241.00 at the end of the last trading period.

With a Neutral rating, Citigroup initiated coverage on BlackLine Inc (NASDAQ:BL). The price target seems to have been set at $73.00 for BlackLine. In the second quarter, BlackLine showed an EPS of $0.07, compared to $0.15 from the year-ago quarter. The current stock performance of BlackLine shows a 52-week-high of $104.64 and a 52-week-low of $49.66. Moreover, at the end of the last trading period, the closing price was at $67.94.

With a Buy rating, Citigroup initiated coverage on Coupa Software Inc (NASDAQ:COUP). The price target seems to have been set at $77.00 for Coupa Software. In the first quarter, Coupa Software showed an EPS of $0.08, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $166.21 and a 52-week-low of $50.54. At the end of the last trading period, Coupa Software closed at $58.40.

Citigroup initiated coverage on Intuit Inc (NASDAQ:INTU) with a Buy rating. The price target for Intuit is set to $538.00. In the fourth quarter, Intuit showed an EPS of $1.10, compared to $1.97 from the year-ago quarter. The current stock performance of Intuit shows a 52-week-high of $645.61 and a 52-week-low of $339.36. Moreover, at the end of the last trading period, the closing price was at $431.78.

Citigroup initiated coverage on Appian Corp (NASDAQ:APPN) with a Neutral rating. The price target for Appian is set to $55.00. In the second quarter, Appian showed an EPS of $0.46, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $66.91 and a 52-week-low of $38.78. Appian closed at $46.90 at the end of the last trading period.

Citigroup initiated coverage on Dropbox Inc (NASDAQ:DBX) with a Neutral rating. The price target for Dropbox is set to $24.00. For the second quarter, Dropbox had an EPS of $0.38, compared to year-ago quarter EPS of $0.40. The current stock performance of Dropbox shows a 52-week-high of $25.80 and a 52-week-low of $19.07. Moreover, at the end of the last trading period, the closing price was at $21.39.

Citigroup initiated coverage on Pegasystems Inc (NASDAQ:PEGA) with a Neutral rating. The price target for Pegasystems is set to $39.00. For the second quarter, Pegasystems had an EPS of $0.38, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $111.73 and a 52-week-low of $35.69. At the end of the last trading period, Pegasystems closed at $36.61.

Raymond James initiated coverage on Midland States Bancorp Inc (NASDAQ:MSBI) with a Market Perform rating. In the second quarter, Midland States Bancorp showed an EPS of $0.98, compared to $0.86 from the year-ago quarter. The stock has a 52-week-high of $30.60 and a 52-week-low of $23.65. At the end of the last trading period, Midland States Bancorp closed at $25.09.

With an Outperform rating, Raymond James initiated coverage on HomeTrust Bancshares Inc (NASDAQ:HTBI). The price target seems to have been set at $30.00 for HomeTrust Bancshares. HomeTrust Bancshares earned $0.39 in the fourth quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $32.60 and a 52-week-low of $22.86. At the end of the last trading period, HomeTrust Bancshares closed at $23.22.

Raymond James initiated coverage on AnaptysBio Inc (NASDAQ:ANAB) with an Outperform rating. The price target for AnaptysBio is set to $35.00. In the second quarter, AnaptysBio showed an EPS of $1.15, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $36.06 and a 52-week-low of $18.20. At the end of the last trading period, AnaptysBio closed at $23.22.

With a Buy rating, Citigroup initiated coverage on Mirum Pharmaceuticals Inc (NASDAQ:MIRM). The price target seems to have been set at $38.00 for Mirum Pharmaceuticals. Mirum Pharmaceuticals earned $0.84 in the second quarter, compared to $1.45 in the year-ago quarter. The current stock performance of Mirum Pharmaceuticals shows a 52-week-high of $30.55 and a 52-week-low of $14.63. Moreover, at the end of the last trading period, the closing price was at $24.98.

With a Neutral rating, Citigroup initiated coverage on Vertex Inc (NASDAQ:VERX). The price target seems to have been set at $15.00 for Vertex. For the second quarter, Vertex had an EPS of $0.06, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $16.97 and a 52-week-low of $9.44. Vertex closed at $13.68 at the end of the last trading period.

With a Buy rating, Citigroup initiated coverage on Box Inc (NYSE:BOX). The price target seems to have been set at $34.00 for Box. For the second quarter, Box had an EPS of $0.28, compared to year-ago quarter EPS of $0.21. The current stock performance of Box shows a 52-week-high of $33.04 and a 52-week-low of $22.31. Moreover, at the end of the last trading period, the closing price was at $25.75.

Citigroup initiated coverage on Monday.Com Ltd (NASDAQ:MNDY) with a Buy rating. The price target for Monday.Com is set to $156.00. Monday.Com earned $0.33 in the second quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $314.28 and a 52-week-low of $85.75. Monday.Com closed at $113.70 at the end of the last trading period.

Jefferies initiated coverage on CTI BioPharma Corp (NASDAQ:CTIC) with a Buy rating. The price target for CTI BioPharma is set to $13.00. In the second quarter, CTI BioPharma showed an EPS of $0.21, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.80 and a 52-week-low of $1.82. CTI BioPharma closed at $6.28 at the end of the last trading period.

JMP Securities initiated coverage on Aviat Networks Inc (NASDAQ:AVNW) with a Market Outperform rating. The price target for Aviat Networks is set to $50.00. In the fourth quarter, Aviat Networks showed an EPS of $0.67, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.18 and a 52-week-low of $23.88. Aviat Networks closed at $31.30 at the end of the last trading period.

With a Buy rating, B of A Securities initiated coverage on Datadog Inc (NASDAQ:DDOG). The price target seems to have been set at $135.00 for Datadog. Datadog earned $0.24 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Datadog shows a 52-week-high of $184.70 and a 52-week-low of $81.12. Moreover, at the end of the last trading period, the closing price was at $104.95.

Citigroup initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Buy rating. The price target for PTC Therapeutics is set to $70.00. For the second quarter, PTC Therapeutics had an EPS of $2.13, compared to year-ago quarter EPS of $1.68. The stock has a 52-week-high of $54.46 and a 52-week-low of $25.01. At the end of the last trading period, PTC Therapeutics closed at $49.94.

With a Sell rating, Citigroup initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA). The price target seems to have been set at $50.00 for Intellia Therapeutics. Intellia Therapeutics earned $1.33 in the second quarter, compared to $1.01 in the year-ago quarter. The current stock performance of Intellia Therapeutics shows a 52-week-high of $119.65 and a 52-week-low of $37.08. Moreover, at the end of the last trading period, the closing price was at $60.06.

Citigroup initiated coverage on Pliant Therapeutics Inc (NASDAQ:PLRX) with a Buy rating. The price target for Pliant Therapeutics is set to $36.00. Pliant Therapeutics earned $0.82 in the second quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.00 and a 52-week-low of $3.96. Pliant Therapeutics closed at $19.28 at the end of the last trading period.

Stifel initiated coverage on AerSale Corp (NASDAQ:ASLE) with a Buy rating. The price target for AerSale is set to $23.00. For the second quarter, AerSale had an EPS of $0.56, compared to year-ago quarter EPS of $0.38. At the moment, the stock has a 52-week-high of $20.89 and a 52-week-low of $12.78. AerSale closed at $19.28 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on Ventyx Biosciences Inc (NASDAQ:VTYX) with a Buy rating. The price target for Ventyx Biosciences is set to $36.00. Ventyx Biosciences earned $0.39 in the second quarter, compared to $4.31 in the year-ago quarter. The current stock performance of Ventyx Biosciences shows a 52-week-high of $27.65 and a 52-week-low of $9.50. Moreover, at the end of the last trading period, the closing price was at $20.40.